|Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients|
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
|Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation|
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
|Heart disease and stroke statistics-2003 update|
American Heart Association
http://www. americanheart. org/downloadable/heart …, 2002
|Antiinflammatory therapy with canakinumab for atherosclerotic disease|
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
|Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events|
DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ...
New England Journal of Medicine 354 (16), 1706-1717, 2006
|Predictors of hospital mortality in the global registry of acute coronary events|
CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ...
Archives of internal medicine 163 (19), 2345-2353, 2003
|Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)|
MD Flather, MC Shibata, AJS Coats, DJ Van Veldhuisen, A Parkhomenko, ...
European heart journal 26 (3), 215-225, 2005
|Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients|
MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ...
The Lancet 355 (9215), 1575-1581, 2000
|ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association …|
V Fuster, LE Rydén, RW Asinger, DS Cannom, HJ Crijns, RL Frye, ...
Journal of the American College of Cardiology 38 (4), 1231-1265, 2001
|A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry|
KA Eagle, MJ Lim, OH Dabbous, KS Pieper, RJ Goldberg, F Van de Werf, ...
Jama 291 (22), 2727-2733, 2004
|Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)|
KAA Fox, OH Dabbous, RJ Goldberg, KS Pieper, KA Eagle, F Van de Werf, ...
bmj 333 (7578), 1091, 2006
|European Society of Cardiology: cardiovascular disease statistics 2019|
A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ...
European heart journal 41 (1), 12-85, 2020
|Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials …|
PR Collins R, Flather M, Parish S, Baigent C
The Lancet 343, 311-322, 1994
|Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis …|
L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ...
The Lancet 376 (9745), 975-983, 2010
|Apixaban with antiplatelet therapy after acute coronary syndrome|
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine 365 (8), 699-708, 2011
|Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006|
KAA Fox, PG Steg, KA Eagle, SG Goodman, FA Anderson, CB Granger, ...
Jama 297 (17), 1892-1900, 2007
|Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial|
DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ...
Journal of the American College of Cardiology 49 (19), 1982-1988, 2007
|Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten …|
MA Hlatky, DB Boothroyd, DM Bravata, E Boersma, J Booth, MM Brooks, ...
The Lancet 373 (9670), 1190-1197, 2009
|Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …|
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
|Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and Non-Q-Wave mayocardial infarction|
Prism-Plus Study Investigators
N Engl J Med 338, 1488-1497, 1998